<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://biotechmorning.com/news/covid-vaccines-annual-update-cycle-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T14:20:22.093Z</news:publication_date>
      <news:title>COVID Vaccines Now Update Like iPhones</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/tezspire-eosinophilic-esophagitis-phase-3-crossing-results</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T14:19:36.937Z</news:publication_date>
      <news:title>Tezspire Just Crashed Dupixent&apos;s Party in a Big Way</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/genentech-dualitybio-adc-resistance-billion-dollar-deal</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T14:18:51.998Z</news:publication_date>
      <news:title>Genentech Just Bet $1 Billion That ADCs Have an Achilles&apos; Heel</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/gilead-bixlenvo-lenacapavir-oral-hiv-pill</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T14:18:04.935Z</news:publication_date>
      <news:title>Gilead Just Put Its Best Injectable Drug in a Tiny Pill</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/rasonque-pancreatic-cancer-fda-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T14:17:19.770Z</news:publication_date>
      <news:title>The Drug That Just Rewrote Pancreatic Cancer&apos;s Worst Odds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/alnylam-heart-drug-wall-street-trust-crisis</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T14:16:34.693Z</news:publication_date>
      <news:title>Alnylam&apos;s Heart Drug Just Hit a Wall Street Trust Crisis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/white-house-midsize-biotech-drug-pricing-deals</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T14:15:47.278Z</news:publication_date>
      <news:title>The White House Is Coming for Midsize Biotech&apos;s Pricing Power</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/sk-biohaven-kv7-epilepsy-deal</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T14:15:04.884Z</news:publication_date>
      <news:title>The $795M Bet on a Brain Channel That Already Failed Once</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/hbv-cccdna-elimination-first-clinical-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T14:14:20.221Z</news:publication_date>
      <news:title>The Virus That Hides a Secret Copy of Itself Just Got Caught</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/metsera-founders-launch-sentivera-inflammation-deal</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T14:13:31.515Z</news:publication_date>
      <news:title>The Duo That Sold a Biotech to Pfizer Is Back With a New One</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/first-pill-dermatomyositis-lisraya-fda-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-28T14:12:44.035Z</news:publication_date>
      <news:title>The First Pill for a Disease That&apos;s Had None</news:title>
    </news:news>
  </url>
</urlset>